Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1550
-0.0050 (-3.13%)
At close: Mar 20, 2026
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 9.77 million as of March 20, 2026. Its market cap has increased by 55.75% in one year.
Market Cap
9.77M
Enterprise Value
11.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 9.77M, a decrease of -23.13%. That is a compound annual growth rate of -5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 9.77M | 24.76% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | 12.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Britannia Life Sciences | 15.41M |
| Hemostemix | 14.64M |
| Rapid Dose Therapeutics | 12.84M |
| PreveCeutical Medical | 11.96M |
| Quantum BioPharma | 11.93M |
| Pharmala Biotech Holdings | 11.44M |
| Innovotech | 9.62M |
| Glow Lifetech | 9.08M |